tm logo
BRAINCHILD BIO
Live/Pending
PUBLISHED FOR OPPOSITION

on 03 Dec 2024

Last Applicant/ Owned by

M/S CURE-10

Seattle

WA

98101

Serial Number

98293774 filed on 01st Dec 2023

Registration Number

N/A

Correspondent Address

Catherine E. Maxson

Catherine E. Maxson Davis Wright Tremaine LLP

Seattle, WA 98104

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

BRAINCHILD BIO

Pharmaceutical and biopharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical and biopharmaceutical preparations for immunotherapy; chemical, biochemical, biologic and cell-based preparations for treatment of cancer; biologic and cell-based preparations for immunotherapy; pharmaceutical and biopharmaceutical substances for use in immunotherapy

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and biopharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical and biopharmaceutical preparations for immunotherapy; chemical, biochemical, biologic and cell-based preparations for treatment of cancer; biologic and cell-based preparations for immunotherapy; pharmaceutical and biopharmaceutical substances for use in immunotherapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98293774

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 17722-559

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Dec 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03rd Dec 2024PUBLISHED FOR OPPOSITION
27th Nov 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
04th Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
04th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
04th Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
13th Aug 2024NON-FINAL ACTION WRITTEN
13th Aug 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
13th Aug 2024NON-FINAL ACTION E-MAILED